Leadless Pacing: Therapy, Challenges and Novelties
Leadless pacing is a rapidly growing field. Initially designed to provide right ventricular pacing for those who were contraindicated for conventional devices, the technology is growing to explore the potential benefit of avoiding long-term transvenous leads in any patient who requires pacing. In th...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Radcliffe Medical Media
2023-04-01
|
| Series: | Arrhythmia & Electrophysiology Review |
| Online Access: | https://www.aerjournal.com/articleindex/aer.2022.41 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850111041900380160 |
|---|---|
| author | Nadeev Wijesuriya Felicity De Vere Vishal Mehta Steven Niederer Christopher A Rinaldi Jonathan M Behar |
| author_facet | Nadeev Wijesuriya Felicity De Vere Vishal Mehta Steven Niederer Christopher A Rinaldi Jonathan M Behar |
| author_sort | Nadeev Wijesuriya |
| collection | DOAJ |
| description | Leadless pacing is a rapidly growing field. Initially designed to provide right ventricular pacing for those who were contraindicated for conventional devices, the technology is growing to explore the potential benefit of avoiding long-term transvenous leads in any patient who requires pacing. In this review, we first examine the safety and performance of leadless pacing devices. We then review the evidence for their use in special populations, such as patients with high risk of device infection, patients on haemodialysis, and patients with vasovagal syncope who represent a younger population who may wish to avoid transvenous pacing. We also summarise the evidence for leadless cardiac resynchronisation therapy and conduction system pacing and discuss the challenges of managing issues, such as system revisions, end of battery life and extractions. Finally, we discuss future directions in the field, such as completely leadless cardiac resynchronisation therapy-defibrillator devices and whether leadless pacing has the potential to become a first-line therapy in the near future. |
| format | Article |
| id | doaj-art-894affab1f974729a50fb573dff306f6 |
| institution | OA Journals |
| issn | 2050-3369 2050-3377 |
| language | English |
| publishDate | 2023-04-01 |
| publisher | Radcliffe Medical Media |
| record_format | Article |
| series | Arrhythmia & Electrophysiology Review |
| spelling | doaj-art-894affab1f974729a50fb573dff306f62025-08-20T02:37:42ZengRadcliffe Medical MediaArrhythmia & Electrophysiology Review2050-33692050-33772023-04-011210.15420/aer.2022.41Leadless Pacing: Therapy, Challenges and NoveltiesNadeev Wijesuriya0Felicity De Vere1Vishal Mehta2Steven Niederer3Christopher A Rinaldi4Jonathan M Behar5chool of Biomedical Engineering and Imaging Sciences, King’s College London, London UK; Department of Cardiology, Guy’s and St Thomas’ NHS Foundation Trust, London, UKchool of Biomedical Engineering and Imaging Sciences, King’s College London, London UK; Department of Cardiology, Guy’s and St Thomas’ NHS Foundation Trust, London, UKchool of Biomedical Engineering and Imaging Sciences, King’s College London, London UK; Department of Cardiology, Guy’s and St Thomas’ NHS Foundation Trust, London, UKchool of Biomedical Engineering and Imaging Sciences, King’s College London, London, UKchool of Biomedical Engineering and Imaging Sciences, King’s College London, London UK; Department of Cardiology, Guy’s and St Thomas’ NHS Foundation Trust, London, UKchool of Biomedical Engineering and Imaging Sciences, King’s College London, London UK; Department of Cardiology, Guy’s and St Thomas’ NHS Foundation Trust, London, UKLeadless pacing is a rapidly growing field. Initially designed to provide right ventricular pacing for those who were contraindicated for conventional devices, the technology is growing to explore the potential benefit of avoiding long-term transvenous leads in any patient who requires pacing. In this review, we first examine the safety and performance of leadless pacing devices. We then review the evidence for their use in special populations, such as patients with high risk of device infection, patients on haemodialysis, and patients with vasovagal syncope who represent a younger population who may wish to avoid transvenous pacing. We also summarise the evidence for leadless cardiac resynchronisation therapy and conduction system pacing and discuss the challenges of managing issues, such as system revisions, end of battery life and extractions. Finally, we discuss future directions in the field, such as completely leadless cardiac resynchronisation therapy-defibrillator devices and whether leadless pacing has the potential to become a first-line therapy in the near future.https://www.aerjournal.com/articleindex/aer.2022.41 |
| spellingShingle | Nadeev Wijesuriya Felicity De Vere Vishal Mehta Steven Niederer Christopher A Rinaldi Jonathan M Behar Leadless Pacing: Therapy, Challenges and Novelties Arrhythmia & Electrophysiology Review |
| title | Leadless Pacing: Therapy, Challenges and Novelties |
| title_full | Leadless Pacing: Therapy, Challenges and Novelties |
| title_fullStr | Leadless Pacing: Therapy, Challenges and Novelties |
| title_full_unstemmed | Leadless Pacing: Therapy, Challenges and Novelties |
| title_short | Leadless Pacing: Therapy, Challenges and Novelties |
| title_sort | leadless pacing therapy challenges and novelties |
| url | https://www.aerjournal.com/articleindex/aer.2022.41 |
| work_keys_str_mv | AT nadeevwijesuriya leadlesspacingtherapychallengesandnovelties AT felicitydevere leadlesspacingtherapychallengesandnovelties AT vishalmehta leadlesspacingtherapychallengesandnovelties AT stevenniederer leadlesspacingtherapychallengesandnovelties AT christopherarinaldi leadlesspacingtherapychallengesandnovelties AT jonathanmbehar leadlesspacingtherapychallengesandnovelties |